NeoPlex (TM) HPV29 Detection, a new molecular detection kit from Genematrix, acquires European CE-IVD certification
Oct 12, 2021
Real-time PCR-based human papillomavirus (HPV) detection product is launched. Simultaneous HPV detection and genotyping of 29 HPV types are available. PANGYO, South Korea, Oct. 12, 2021 /PRNewswire/ -- Genematrix (KRX 109820), specialized in real-time PCR based molecular diagnostics, announced that 'NeoPlex™ HPV29 Detection', which can collectively diagnose 29 genotypes of human papillomavirus (HPV; the causative agent of cervical cancer) and simultaneously identify the virus genotype a